SCHEMBL5558141

SCHEMBL5558141

O=C1c2ccccc2C(=O)N1OCc1ccc2ccccc2c1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.62
▸ KMT2A Q03164 4/20 0.62
▸ MAPT P10636 1/20 0.62
▸ GAA P10253 2/20 0.49
▸ ALDH1A1 P00352 6/20 0.47
▸ HTT P42858 1/20 0.47
▸ POLB P06746 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ ATM Q13315 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CYP1A2 P05177 3/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RECQL P46063 1/20 0.42
▸ TNF P01375 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5558757 0.82 MEN1 (0.52) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL24370231 0.79 L3MBTL1 (0.51) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL29367470 0.79 KMT2A (0.74) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL6524461 0.79 KMT2A (0.74) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL24168448 0.78 MEN1 (0.59) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL22895135 0.78 MEN1 (0.59) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL5528619 0.78 MEN1 (0.73) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL5554044 0.78 MEN1 (0.51) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL5525817 0.77 MEN1 (0.67) MEN1KMT2AMAPTGAAPOLB
SCHEMBL5524437 0.77 NR1H2 (0.58) MEN1KMT2AMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE39591-E1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2007-04-24 — — US disclosed
EP-1291351-B1 6-0 substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-07-13 — — EP disclosed
EP-0929563-B1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY ABBOTT LAB (US) 2005-06-01 — — EP disclosed
EP-1291353-B1 6-O-substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-06-01 — — EP disclosed
EP-1291352-B1 6-O-substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-05-25 — — EP disclosed
EP-1291350-B1 6-0 substituted ketolides having antibacterial activity ABBOTT LAB (US) 2005-05-25 — — EP disclosed
EP-1291351-A1 6-0 substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
EP-1291352-A1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
EP-1291350-A1 6-0 substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
EP-1291353-A1 6-O-substituted ketolides having antibacterial activity ABBOTT LABORATORIES (US) 2003-03-12 — — EP disclosed
US-6147197-A INCREASED ACID STABILITY AND ENHANCED ACTIVITY TOWARD GRAM NEGATIVE BACTERIA AND MACROLIDE RESISTANT GRAM POSITIVE BACTERIA ABBVIE INC. 2000-11-14 — — US disclosed
US-6075133-A INCREASED ACID STABILITY AND ENHANCED BACTERICIDAL ACTIVITY ABBOTT LABORATORIES (US) 2000-06-13 — — US disclosed
US-6028181-A 6-0-Substituted antibacterial erythromycin ketolides and methods of making ABBOTT LABORATORIES (US) 2000-02-22 — — US disclosed
EP-0929563-A1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY Abbott Laboratories (US) 1999-07-21 — — EP disclosed
US-5866549-A MACROLIDE ANTIBIOTICS ABBOTT LABORATORIES (US) 1999-02-02 — — US disclosed
WO-1998009978-A1 6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY ABBOTT LABORATORIES (US) 1998-03-12 — — WO disclosed
Send feedback